You are here

Bayer considering sale of its diabetes device business


BAYER AG is exploring the sale of its diabetes device business as the German company focuses on faster-growing medicines, according to people with knowledge of the matter.

Leverkusen, Germany-based Bayer is working with Credit Suisse Group AG on the potential sale, three of

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom